In this theory-informed auto-ethnographic account, I relate my experience of participating in the EuroScience Open Forum Conference 2018 (ESOF). Gender equality was certainly on the agenda at ESOF, however, I argue that the manner in which gender equality was addressed at the conference is not only problematic but potentially counter-productive to the intended purpose of promoting women in research careers. If we keep 1) essentialising a presumed lack of confidence to women, 2) omitting men’s role in the reproduction of gender hierarchies in research from equality discussions, and 3) excluding gender scholars’ expertise from gender equality debates, I fear that women’s equal participation in academic research and leadership will remain a distant prospect in the future still. Read more [...]
EuroScientist is off for a summer break!
In the meantime, help us sign and spread the petition to double the EU Budget for Research and Innovation compared to Horizon 2020.
The #DoubleRIEU petition is an initiative from EuroScience and Initiative for Science in Europe. Read more [...]
This special issue of EuroScientist offers a sneak preview or if you wish a sneak preread of what you will witness at ESOF 2018 Toulouse. Read more [...]
In the rapidly evolving global research enterprise, new scientific and societal challenges require multidisciplinary approaches and the involvement of a higher and diverse number of stakeholders. Accordingly, researchers are increasingly required to work across disciplines, sectors and institutions at regional, national and international levels.
Researchers associations are an invaluable resource to support researchers along their career development and to foster researchers communities.
How many combinations could be imagined to bring together researchers associations and to foster researcher's networking beyond national and discipline borders?
The session aims at collecting input as a basis for a strategy on how to systematise the collaboration between important actors in the field of research career development. Read more [...]
The "Lost Generation" refers to the growing cohort of senior post-doctoral researchers and other scientists who, after completing short-term contracts and temporary positions, find themselves excluded from research careers due to the lack of opportunities for permanent research positions. This cohort must contend with a ‘game’ whose rules no longer apply in today’s overcrowded and hyper-competitive research environment. Often, the difficulty in obtaining a full-time research position is further exacerbated by geographical, social, and familial constraints, and a lack of transferable skills that would enable a career switch. The loss of these highly trained individuals to our research institutions and to industry creates instability and represents an inefficient use of human talent and financial resources. Although the problem is not new, it is a critical issue and more needs to be done to address the needs of this cohort. Our goal is to launch a discussion with all relevant stakeholders toward actionable ideas to these systemic problems. Read more [...]
In the words of one of the 2017 PhD European Young Researcher Award winners, a scientist’s life often means “no fixed working hours, being switched on always, and yet getting paid only when you have a grant or a scholarship.” This opinion piece by Satyajit Rout from Editage, a science communication services company that supports researchers and institutions drive real-world scientific impact, delves into the challenges facing young scientists and suggests what could be done to change the status quo. Read more [...]
Newer genome editing technologies, such as CRISPR-Cas, are revolutionising scientific research and bringing about a myriad of potential applications in many fields. For science and technology to progress timely and efficiently, the societal debate must move forward at the same pace to help guide the direction of scientific research and to frame policy-making decisions. As this technology progresses, what will be the key questions to address as the public is engaged in these conversations? This article hints at some of them while a comprehensive list will be discussed at ESOF dilemma café session on Friday 13th –participate to find out! Read more [...]
Patients are the end users of health research; however, they are still rarely implicated in health research. In the 80’s HIV patients have revolted against this position and have invited themselves to scientific conferences and they have contributed to a major change in patient involvement in HIV research. How have other fields of biomedical research, like rare disease research or cancer research, been inspired by this unique experience? Read more [...]
Recently, there has been an increasing amount of attention paid to the mental health of researchers. Research is an activity that aims to confront the boundaries of human knowledge: it demands excellence from all researchers, who aim to publish in peer-reviewed publications, submit grant applications, achieve tenure or defend a PhD thesis. Researchers identify with and are dedicated to their work to a very great extent. A recent report noted that researchers simultaneously demonstrate high levels of job satisfaction and high levels of stress and depression. Nevertheless, hard work does not have to lead to suffering. Read more [...]
The term ‘value’ is at the centre of an increasingly explicit debate in the fields of health and healthcare policy. ‘Value’ is understood in many different ways and diverging interests are being mobilised. How are values in biomedical innovation being expressed, represented, materialised and aligned or contested in different areas of biomedicine? How do values embedded in regulation, public health, economic policies, healthcare provision, technology assessment, producers' strategies, and patient organisation movements shape biomedical innovations? At an ESOF discussion in Toulouse multidisciplinary perspectives on value between panel members and public participants will be explored and possible pathways to common solutions identified that promote socially acceptable biomedical innovation in the European context. Read more [...]